miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer-Reference-Cited by-同舟云学术

miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer

Published:2019-11 Issue: Volume:119 Page:109406
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Liu Shangwen,Wang Yadong,Li Wengang,Yu Shaolong,Wen Zhipeng,Chen Zhifeng,Lin Feng

Funder

Shenzhen Municipal Science and Technology Innovation Committee

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference26 articles.

1. Landmarks in the diagnosis and treatment of renal cell carcinoma;Bhatt;Nat. Rev. Urol.,2014

2. Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy, Science China;Zheng;Life Sci.,2017

3. Radiotherapy for renal-cell carcinoma;De Meerleer;Lancet Oncol.,2014

4. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Buti;Anti-Cancer Drugs,2013

5. Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma;Jin;Int. J. Clin. Exp. Med.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology and epigenetic modifications definition;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Biomarkers in renal cell carcinoma and their targeted therapies: a review;Exploration of Targeted Anti-tumor Therapy;2023-10-25

3. Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response;Pharmacological Research;2023-03

4. miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction;International Journal of Molecular Sciences;2022-12-02

5. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer;Urologic Cancers;2022-09-12